These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11521625)

  • 1. When to screen for hepatitis C virus. Applying the principles of evidence-based medicine.
    Hummel J
    JAAPA; 2000 Sep; 13(9):77-82. PubMed ID: 11521625
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C and general practice: the challenge continues.
    Kidd M
    Aust Fam Physician; 2003 Oct; 32(10):795. PubMed ID: 14596072
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge.
    Sterling RK
    Am J Gastroenterol; 2003 Oct; 98(10):2130-4. PubMed ID: 14572556
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidemiologic and therapeutic status study of patients with hepatitis C].
    Xu M; Shi HY; Cai WP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):135-6. PubMed ID: 21863640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C.
    Colletta C; Smirne C; Marini C; Pirisi M
    J Clin Gastroenterol; 2008 Feb; 42(2):219-20. PubMed ID: 18209600
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-hepatitis C virus coinfection: questions and answers.
    Valenti WM
    AIDS Read; 2005 Mar; 15(3):110-2, 117, 127-8. PubMed ID: 15786572
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward evidence based control of hepatitis C virus infection.
    Miyamura T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1195. PubMed ID: 17889399
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C: in 2015, who should be screened first?].
    Nau JY
    Rev Med Suisse; 2015 Apr; 11(470):888-9. PubMed ID: 26050310
    [No Abstract]   [Full Text] [Related]  

  • 12. HCV genotype 5: epidemiology and spread of an uncommon genotype.
    Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
    J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment for hepatitis C in patients infected with human immunodeficiency virus.
    Fernández I; Muñoz R; Solís-Herruzo JA
    Rev Esp Enferm Dig; 2003 Apr; 95(4):287-91, 282-6. PubMed ID: 12826005
    [No Abstract]   [Full Text] [Related]  

  • 14. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity.
    Campisi G; Di Fede O; Craxi A; Di Stefano R; Margiotta V
    J Am Acad Dermatol; 2004 Sep; 51(3):364-70. PubMed ID: 15337978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
    Fontana M; Ciuffreda D; Moradpour D; Pascual M
    Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091
    [No Abstract]   [Full Text] [Related]  

  • 18. Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C.
    Fabris P; Tositti G; Giordani MT; Infantolino D; de LF
    Am J Gastroenterol; 2002 Feb; 97(2):492-3. PubMed ID: 11866300
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
    AASLD/IDSA HCV Guidance Panel
    Hepatology; 2015 Sep; 62(3):932-54. PubMed ID: 26111063
    [No Abstract]   [Full Text] [Related]  

  • 20. Micro-elimination of hepatitis C virus infection - the beginning of the end.
    Huiban L; Stanciu C; Sfarti C; Muzica C; Cuciureanu T; Zenovia S; Frunzuc G; Damian I; Trifan A
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):688. PubMed ID: 33331344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.